Gong, L., Sun, H., Liu, L., Sun, X., Fang, T., Yu, Z., Sui, W., Xu, J., Wang, T., Feng, F., Lei, L., Rui, W., Liu, Y., Zhao, X., An, G., Lin, X., Qiu, L. and Hao, M. (2020) “LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285099.